AURA — Aura Biosciences, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2021-10-29.
Performance
Technicals
Others in Healthcare
Measured signals that fired on AURA
| date | signal | measured base rate |
|---|---|---|
| 2026-08-19 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-08-17 | Volume shock without a price move price | -1.33% over 21 days · t = -4.53 · n = 16,432 statistically distinguishable from its control group |
| 2026-06-11 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-05-05 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-07-07 | Bender Jeremy Director | Grant or award | 30.0K | 0.00 | 0 |
| 2026-07-01 | Kilroy Conor See Remarks | Grant or award | 14.9K | 0.00 | 0 |
| 2026-06-16 | Gibney Anthony S See Remarks | Open-market sale | 12.8K | 6.42 | 82.3K |
| 2026-06-11 | Srivastava Sapna Director | Grant or award | 15.0K | 0.00 | 0 |
| 2026-06-11 | Mattessich Antony C. Director | Grant or award | 15.0K | 0.00 | 0 |
| 2026-06-11 | Bitetti Teresa Marie Director | Grant or award | 15.0K | 0.00 | 0 |
| 2026-06-11 | Johnson David Michael Director | Grant or award | 15.0K | 0.00 | 0 |
| 2026-05-19 | Holles Natalie C. See Remarks | Grant or award | 553.8K | 0.00 | 0 |
| 2026-05-19 | Holles Natalie C. See Remarks | Grant or award | 600.1K | 0.00 | 0 |
| 2026-05-07 | Matrix Capital Management Company, LP 10% owner | Open-market sale | 6.9M | 5.64 | 39.0M |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| Matrix Capital Management Company, LP | 46.3M | 6.9M |
| Frazier Life Sciences Management, L.P. | 34.1M | 5.1M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 32.7M | 4.9M |
| Long Focus Capital Management, LLC | 30.9M | 4.6M |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 29.3M | 4.4M |
| BlackRock, Inc. | 24.0M | 3.6M |
| Medicxi Ventures Management (Jersey) Ltd | 20.3M | 3.0M |
| VANGUARD CAPITAL MANAGEMENT LLC | 15.0M | 2.2M |
| Nantahala Capital Management, LLC | 14.2M | 2.1M |
| FRANKLIN RESOURCES INC | 13.9M | 2.1M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Aura Biosciences, Inc. (AURA) filed form 8-K · 2026-08-11 · SEC EDGAR
Ask the AI about AURA
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →